International Journal of Clinical Research

Objective To explore the value of using modified minimally invasive hematoma aspiration surgery in the treatment of cerebral hemorrhage patients. Methods Sixty six patients with cerebral hemorrhage admitted to our hospital from June 2020 to June 2021 were selected for observation, and were divided into two groups according to different treatment plans. The study group (33 cases, treated with modified minimally invasive hematoma aspiration) and the control group (33 cases, treated with conventional minimally invasive hematoma aspiration). Compare the initial suction volume and post-treatment prognosis (BI index) between two groups of patients during suction therapy, observe and record the recurrence of cerebral hemorrhage after treatment, as well as the specific situation of death after treatment. Results During the treatment period, the total amount of initial aspiration in the study group was much lower than that in the control group, and the BI index of patients after treatment was higher than that in the control group (P<0.05). After treatment, the incidence of recurrent cerebral hemorrhage in the study group was lower than that in the control group, and the number of deaths in patients after treatment was also lower than that in the control group (P<0.05). Conclusion The use of an improved version of minimally invasive hematoma aspiration surgery for the treatment of patients with cerebral hemorrhage can significantly reduce the incidence of rebleeding, improve the prognosis and survival of patients, and is worthy of promotion.

Cerebral hemorrhage; Improved minimally invasive hematoma aspiration surgery; First suction volume; Prognostic effect